Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Conclusions.
COVID-19 severity in KT patients has remained high and has not improved despite receiving 2 doses of the mRNA vaccine. The mRNA-1273 vaccine shows higher clinical effectiveness than BNT162b2 in KT recipients with breakthrough infections. Confirmation of these data will require further research taking into account the new variants and the administration of successive vaccine doses.
Source: Transplantation - Category: Transplant Surgery Tags: Original Clinical Science—General Source Type: research
More News: Coronavirus | Covid Vaccine | COVID-19 | Kidney Transplant | Kidney Transplantation | Pneomococcal Vaccine | Pneumonia | SARS | Spain Health | Transplant Surgery | Transplants | Urology & Nephrology | Vaccines